Laden...
Having trouble viewing this email? View it as a Web page. You are receiving this message because you are subscribed to News Releases for National Institutes of Health (NIH). NIH study finds that immunotherapy substantially increases survival of people with lymphomatoid granulomatosis 04/04/2023 02:15 PM EDTPatients treated with interferon alfa-2b lived for decades after diagnosis in Phase 2 trial.
|
Laden...
Laden...
© 2024